Altria reported second-quarter 2026 net revenue of $6.1 billion, topping market expectations, while adjusted earnings per share of $1.48 missed estimates by 2 cents, according to an SEC Form 8-K filing released on July 30 (local time).
📊 Price at Time of Writing (July 30, 2026, 21:00 KST)
$74.92 ▲ +0.13%
Q2 Results at a Glance
Second-quarter net revenue was $6.111 billion, nearly unchanged from a year earlier. Gains in the smokeable products and other segments were offset by a decline in oral tobacco product sales. Revenue net of excise taxes rose 1.2% to $5.356 billion.
- Net revenue: $6.111 billion, up 0.1% year-over-year (essentially flat)
- Adjusted EPS: $1.48, up 2.8% year-over-year but 2 cents below the consensus estimate
- GAAP EPS: $1.37, down 2.8% year-over-year
- First-half net revenue: $11.539 billion, up 1.6% year-over-year
- First-half adjusted EPS: $2.80, up 4.9% year-over-year
Outlook
Altria narrowed its full-year 2026 adjusted EPS guidance to $5.61-$5.72, representing growth of 3.5-5.5% over the 2025 base of $5.42. The company raised the low end of its guidance range, signaling confidence in its results. CEO Sal Mancuso said, "We delivered solid results in the first half, and returned approximately $3.9 billion to shareholders through dividends and share repurchases combined." The company also raised its 2026 capital expenditure outlook from $300-375 million to $375-450 million, reflecting increased investment in consolidating its cigarette manufacturing facilities.
Market Reaction
According to media reports, Altria's adjusted EPS missed consensus estimates by 2 cents, while revenue beat expectations. At the time of the earnings release, Altria shares traded at $74.92, up 0.13% from the previous session. The mixed results — an EPS miss against a revenue beat — appear to have kept the stock largely stable.
This article was automatically generated based on the original SEC Form 8-K filing and media reports, with the goal of delivering key data quickly following the announcement. Readers are advised to review the company's official filing before making trading decisions. Prices reflect the time of writing and may differ from current levels.
